Trials / Completed
CompletedNCT01873027
OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON
OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON (OPINION)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 829 (actual)
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan · Academic / Other
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this randomized study is to evaluate the impact of Optical frequency domain imaging (OFDI) guidance for Percutaneous Coronay Intervention (PCI) with drug-eluting stent (DES) as compared with Intravascular ultrasound (IVUS) guidance.
Detailed description
Optical frequency domain imaging (OFDI) is a novel, high resolution intravascular imaging modality. Intravascular ultrasound (IVUS) is a widely used conventional imaging modality for achieving optimal stent deployment. The aim of this randomized study is to evaluate the impact of OFDI guidance for Percutaneous Coronay Intervention (PCI) with drug-eluting stent (DES) as compared with IVUS guidance. We will enroll 800 patients with a de novo lesion who will undergo PCI with DES as is routine practice. Patients will be rondomely assigned to either OFDI-guided PCI arm or IVUS-guided PCI arm. Patients will then have a follow-up contact at the time of hospital discharge, 8 month and 12 month after PCI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OFDI | * OFDI-guided PCI and assessment by OFDI at pre-PCI and post-PCI * Follow-up contact at the time of hospital discharge, 8 months and 12months after PCI |
| DEVICE | IVUS | * IVUS-guided PCI and assessment by IVUS at pre-PCI and post-PCI * Follow-up contact at the time of hospital discharge, 8 months and 12months after PCI |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2013-06-07
- Last updated
- 2016-07-14
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01873027. Inclusion in this directory is not an endorsement.